IRCT20160531028188N4 IRCT 2018-03-05 Mazandaran University of Medical Sciences Effect of Bilinoeid drop on neonatal jaundice Assessment of the effect of Bilinoeid drop on neonatal jaundice 2017-09-23 anticipated 100 Complete https://irct.ir/trial/27765 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: A computer software program is used to produce random numbers to allocate the medication and placebo to two groups. Adequate medication and placebo for each group will be placed in a special envelope marked with patient number and medication code, Blinding description: For blinding in this trial, similarity of interventions in the two treatment groups under study was anticipated. The placebo was prepared in similar packages, with all the same physical and similar properties (in terms of color, odor, consistency, etc.). The amount of ingestion and the number of times a day was the same in both products. The only difference in these two products was the code inserted (numerical code) on the package and the corresponding box. Patients, doctor and assessor will have no knowledge of the nature of medication or group allocation. Bilinoeid and placebo drops (medication and placebo) are provided by the laboratory of Sari Pharmacy Faculty. 2 Neonatal jaundice. Intervention 1: Intervention group: The neonate with jaundice will receives cotoneaster manna drop which is prescribed about 1 g manna per day that is divided into 3 doses (every 8 hour) and at most until 5 days. Intervention 2: Control group: The neonate with jaundice will receive placebo. The number of placebo drops per day is similar to the number of cotoneaster drops that is divided into 3 doses (every 8 hour) and at most until 5 days. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information